Characterization of secondary care for COPD in Sweden

References

• Backman H , Eriksson B , Rönmark E , et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:1–8. DOI:10.1016/j.rmed.2016.03.013
   Web of Science ®Google Scholar
• Danielsson P , Ólafsdóttir IS , Benediktsdóttir B , et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden–the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6(2):120–127. DOI:10.1111/j.1752-699X.2011.00257.x
   Web of Science ®Google Scholar
• Torén K , Olin A-C , Lindberg A , et al. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS). Int J Chron Obstruct Pulmon Dis. 2016;11:927–933. DOI:10.2147/COPD.S104644
   PubMed Web of Science ®Google Scholar
• Lozano R , Naghavi M , Foreman K , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. DOI:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Sundh J , Janson C , Lisspers K , et al. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7:833–842. DOI:10.2147/COPD.S38119
   PubMed Web of Science ®Google Scholar
• Swedish National Board of Health and Welfare . Socialstyrelsens riktlinjer för vård av astma och kroniskt obstruktiv lungsjukdom. Faktadokument och beslutsstöd för prioriteringar. Swedish National Board of Health and Welfare; 2004. Available from http://www.socialstyrelsen.se/english
   Google Scholar
• Agency SMP . Chronic Obstructive Pulmonary Disease (COPD)- treatment recommendation. 2015 [ updated 2015 Oct 16]. Available from: https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/Kroniskt_obstruktiv_lungsjukdom_KOL_behandlingsrekommendation.pdf
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. [ updated 2016; cited 2016 Jun 14]. Available from: http://www.goldcopd.com
   Google Scholar
• Sundh J , Ställberg B , Lisspers K , et al. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD. 2011;8(3):173–181. DOI:10.3109/15412555.2011.560130
   PubMedGoogle Scholar
• Kruis AL , Ställberg B , Jones RCM , . Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. Plos One. 2014;9(3):e90145. DOI:10.1371/journal.pone.0090145
   PubMed Web of Science ®Google Scholar
• Sundh J , Johansson G , Larsson K , et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173–183. DOI:10.2147/COPD.S74645
   PubMed Web of Science ®Google Scholar
• Sundh J , Johansson G , Larsson K , et al. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:2327–2334. DOI:10.2147/COPD.S91362
   PubMed Web of Science ®Google Scholar
• Wedzicha JA , Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. DOI:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Landbo C , Prescott E , Lange P , et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. DOI:10.1164/ajrccm.160.6.9902115
   PubMed Web of Science ®Google Scholar
• Tashkin DP , Celli B , Senn S , et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. DOI:10.1056/NEJMoa0805800
   PubMed Web of Science ®Google Scholar
• Calverley PMA , Anderson JA , Celli B , et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789. DOI:10.1056/NEJMoa063070
   PubMed Web of Science ®Google Scholar
• Wedzicha JA , Banerji D , Chapman KR , et al. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med. 2016;374:2222–2234. DOI:10.1056/NEJMoa1516385
   PubMed Web of Science ®Google Scholar
• Welte T , Miravitlles M , Hernandez P , et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741–750. DOI:10.1164/rccm.200904-0492OC
   PubMed Web of Science ®Google Scholar
• Lee S-D , Xie C-M , Yunus F , et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: a randomized, multicentre study in East Asia. Respirology. 2016;21(1):119–127. DOI:10.1111/resp.12646
   PubMed Web of Science ®Google Scholar
• Schembri S , Morant S , Winter JH , et al. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax. 2009;64(7):567–572. DOI:10.1136/thx.2008.106286
   PubMed Web of Science ®Google Scholar
• Stone RA , Harrison BD , Lowe D , et al. Introducing the national COPD resources and outcomes project. BMC Health Serv Res. 2009;9:173. DOI:10.1186/1472-6963-9-173
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793.
   Google Scholar
• Puhan MA , Gimeno-Santos E , Scharplatz M , et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD005305.
   Google Scholar
• Stoilkova A , Janssen DJA , Wouters EFM. Educational programmes in COPD management interventions: a systematic review. Respir Med. 2013;107(11):1637–1650. DOI:10.1016/j.rmed.2013.08.006
   PubMed Web of Science ®Google Scholar
• Zwerink M , Brusse-Keizer M , van der Valk PD , et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014 Mar 19;(3):CD002990.
   Google Scholar
• Bourbeau J , Nault D , Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns. 2004;52(3):271–277. DOI:10.1016/S0738-3991(03)00102-2
   PubMed Web of Science ®Google Scholar
• Koff PB , Jones RH , Cashman JM , et al. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33(5):1031–1038. DOI:10.1183/09031936.00063108
   PubMed Web of Science ®Google Scholar
• Benzo R , Vickers K , Novotny PJ , et al. Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. Am J Respir Crit Care Med. 2016;194:672–680. DOI:10.1164/rccm.201512-2503OC
   Web of Science ®Google Scholar
• Löfdahl C-G , Tilling B , Ekström T , et al. COPD health care in Sweden - A study in primary and secondary care. Respir Med. 2010;104(3):404–411. DOI:10.1016/j.rmed.2009.10.007
   PubMed Web of Science ®Google Scholar
• Sundh J , Österlund Efraimsson E , Janson C , et al. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22(4):393–399. DOI:10.4104/pcrj.2013.00087
   PubMedGoogle Scholar
• Lisspers K , Johansson G , Jansson C , et al. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study. Respir Med. 2014;108(9):1345–1354. DOI:10.1016/j.rmed.2014.06.002
   PubMed Web of Science ®Google Scholar
• Glaab T , Vogelmeier C , Hellmann A , et al. Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J Chron Obstruct Pulmon Dis. 2012;7:101–108. DOI:10.2147/COPD.S27887
   PubMed Web of Science ®Google Scholar